U.S. Physical Therapy, Inc. (NYSE:USPH) Given Consensus Rating of "Buy" by Brokerages

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report) have been assigned a consensus rating of "Buy" from the six brokerages that are presently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $109.00.

A number of brokerages have recently commented on USPH. Barrington Research reduced their target price on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating on the stock in a research report on Friday, February 28th. William Blair reissued a "market perform" rating on shares of U.S. Physical Therapy in a research note on Thursday, February 27th. JPMorgan Chase & Co. dropped their target price on U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating on the stock in a research report on Wednesday, March 19th. Wall Street Zen raised U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Thursday, May 8th. Finally, JMP Securities reaffirmed a "market outperform" rating and set a $113.00 price objective on shares of U.S. Physical Therapy in a research report on Tuesday, April 22nd.

Insider Activity

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of U.S. Physical Therapy stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $82.11, for a total transaction of $142,050.30. Following the completion of the sale, the chief operating officer now owns 7,168 shares of the company's stock, valued at approximately $588,564.48. The trade was a 19.44% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 2.00% of the company's stock.

Institutional Trading of U.S. Physical Therapy

Several institutional investors and hedge funds have recently bought and sold shares of the business. Wells Fargo & Company MN grew its holdings in U.S. Physical Therapy by 2.2% during the fourth quarter. Wells Fargo & Company MN now owns 112,959 shares of the company's stock worth $10,021,000 after acquiring an additional 2,465 shares during the period. PNC Financial Services Group Inc. grew its position in shares of U.S. Physical Therapy by 37.4% in the fourth quarter. PNC Financial Services Group Inc. now owns 4,605 shares of the company's stock valued at $409,000 after purchasing an additional 1,254 shares during the period. Copeland Capital Management LLC increased its stake in U.S. Physical Therapy by 9.5% during the 4th quarter. Copeland Capital Management LLC now owns 839,356 shares of the company's stock worth $74,459,000 after buying an additional 72,715 shares in the last quarter. Proficio Capital Partners LLC purchased a new position in shares of U.S. Physical Therapy in the fourth quarter valued at approximately $3,526,000. Finally, Bridge City Capital LLC boosted its stake in shares of U.S. Physical Therapy by 7.0% in the fourth quarter. Bridge City Capital LLC now owns 64,947 shares of the company's stock worth $5,761,000 after acquiring an additional 4,235 shares during the last quarter.

U.S. Physical Therapy Trading Down 1.5%

Shares of NYSE:USPH traded down $1.17 during trading hours on Friday, hitting $76.12. 4,263 shares of the company's stock traded hands, compared to its average volume of 110,646. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. The business has a fifty day moving average price of $71.96 and a 200-day moving average price of $83.49. U.S. Physical Therapy has a 1 year low of $62.77 and a 1 year high of $105.80. The firm has a market capitalization of $1.16 billion, a P/E ratio of 80.97, a price-to-earnings-growth ratio of 3.54 and a beta of 1.44.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.48 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.46 by $0.02. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The company had revenue of $183.79 million during the quarter, compared to analysts' expectations of $176.78 million. During the same quarter in the previous year, the business earned $0.51 EPS. U.S. Physical Therapy's revenue was up 18.0% compared to the same quarter last year. Equities analysts expect that U.S. Physical Therapy will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 13th. Investors of record on Friday, May 23rd will be paid a dividend of $0.45 per share. The ex-dividend date of this dividend is Friday, May 23rd. This represents a $1.80 annualized dividend and a yield of 2.36%. U.S. Physical Therapy's dividend payout ratio (DPR) is 82.57%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.